We are live on
!
Find out more
IA
IFP Advisors Portfolio holdings
AUM
$5.54B
1-Year Est. Return
27.43%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
–
AUM
$2.21B
AUM Growth
-$312M
(-12%)
Cap. Flow
-$405M
Cap. Flow
% of AUM
-18.36%
Top 10 Holdings %
Top 10 Hldgs %
15.84%
Holding
4,455
New
192
Increased
859
Reduced
2,110
Closed
499
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$5.08M |
| 2 |
DuPont de Nemours
DD
|
+$4.09M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.7M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.43M |
| 5 |
Capital City Bank Group
CCBG
|
+$3.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$16.1M |
| 2 |
ExxonMobil
XOM
|
+$15.9M |
| 3 |
AT&T
T
|
+$12.6M |
| 4 |
Apple
AAPL
|
+$11.8M |
| 5 |
BP
BP
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 5.44% |
| 3 | Healthcare | 5.11% |
| 4 | Consumer Discretionary | 4.03% |
| 5 | Industrials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPG
1401
DELISTED
Interpublic Group of Companies
IPG
| $99K | ﹤0.01% |
4,893
-1,137
| -19% | -$22.7K |
|
|
CONE
1402
DELISTED
CyrusOne Inc Common Stock
CONE
| $99K | ﹤0.01% |
1,669
-44
| -3% | -$2.67K |
|
|
XEC
1403
DELISTED
CIMAREX ENERGY CO
XEC
| $99K | ﹤0.01% |
810
-142
| -15% | -$16.6K |
|
1404
Ambarella
AMBA
$2.99B
| $98K | ﹤0.01% |
1,666
-430
| -21% | -$23.9K |
|
1405
Scotiabank
BNS
$106B
| $98K | ﹤0.01% |
1,517
-448
| -23% | -$29K |
|
1406
Celanese
CE
$4.87B
| $98K | ﹤0.01% |
915
+39
| +4% | +$4.14K |
|
|
VISN
1407
Vistance Networks Inc
VISN
$2.67B
| $98K | ﹤0.01% |
2,593
-37
| -1% | -$1.29K |
|
1408
Franco-Nevada
FNV
$41.4B
| $98K | ﹤0.01% |
1,230
-175
| -12% | -$14K |
|
1409
Omnicom Group
OMC
$23.5B
| $98K | ﹤0.01% |
1,346
+367
| +37% | +$26.3K |
|
1410
Whirlpool
WHR
$2.44B
| $98K | ﹤0.01% |
583
-334
| -36% | -$56.6K |
|
1411
Capitol Federal Financial
CFFN
$1.07B
| $97K | ﹤0.01% |
7,218
-10,063
| -58% | -$141K |
|
1412
Fresenius Medical Care
FMS
$13.4B
| $97K | ﹤0.01% |
1,855
-18
| -1% | -$894 |
|
|
PFN
1413
PIMCO Income Strategy Fund II
PFN
$693M
| $97K | ﹤0.01% |
9,317
-17,522
| -65% | -$184K |
|
1414
Toll Brothers
TOL
$14.1B
| $97K | ﹤0.01% |
2,011
-782
| -28% | -$36K |
|
1415
Campbell Soup
CPB
$6.67B
| $96K | ﹤0.01% |
2,004
-10,318
| -84% | -$490K |
|
1416
Louisiana-Pacific
LPX
$5.19B
| $96K | ﹤0.01% |
3,662
+29
| +0.8% | +$786 |
|
1417
PACCAR
PCAR
$70.2B
| $96K | ﹤0.01% |
2,036
-1,107
| -35% | -$52.4K |
|
1418
PetMed Express
PETS
$42.1M
| $96K | ﹤0.01% |
2,100
-12,642
| -86% | -$498K |
|
1419
Rogers Corp
ROG
$2.31B
| $96K | ﹤0.01% |
591
-1
| -0.2% | -$151 |
|
|
HA
1420
DELISTED
Hawaiian Holdings, Inc.
HA
| $96K | ﹤0.01% |
2,411
-60
| -2% | -$2.31K |
|
|
IPXL
1421
DELISTED
Impax Laboratories, Inc.
IPXL
| $96K | ﹤0.01% |
5,748
+150
| +3% | +$2.75K |
|
|
CY
1422
DELISTED
Cypress Semiconductor
CY
| $96K | ﹤0.01% |
6,332
-4,124
| -39% | -$65.5K |
|
1423
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.08B
| $95K | ﹤0.01% |
4,079
-4,606
| -53% | -$104K |
|
1424
Glacier Bancorp
GBCI
$6.38B
| $95K | ﹤0.01% |
2,415
| – | – |
|
1425
Open Text
OTEX
$5.73B
| $95K | ﹤0.01% |
2,664
+2,626
| +6,911% | +$87.6K |
|
Similar funds
AS
DSC
PA
PWM
SC
EW
GVAG
SWP
IFP Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, IFP Advisors held 4,455 positions worth $2.21B, down 12% from $2.52B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
IFP Advisors withdrew a net $405M in Q4 2017, closing 499 positions and reducing 2,110 holdings. Its most notable exit was ProShares Large Cap Core Plus, an estimated $2.47M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, IFP Advisors opened a new position in DuPont de Nemours worth $4.1M.
- IFP Advisors's largest Q4 2017 buy was DuPont de Nemours: 22,718 shares worth $4.1M.
- IFP Advisors added most to iShares Biotechnology ETF in Q4 2017, an estimated $5.08M increase.
- IFP Advisors's biggest Q4 2017 reduction was Procter & Gamble, cutting an estimated $16.1M.
- IFP Advisors fully exited ProShares Large Cap Core Plus in Q4 2017, selling an estimated $2.47M.
- IFP Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2017.
- IFP Advisors opened 192 new positions and closed 499 in Q4 2017.
- IFP Advisors's portfolio value fell 12% quarter-over-quarter to $2.21B.
Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.